Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics.
- Provides efficacy research on ketamine as a treatment for depression
- Identifies best practices for clinical use, both long-term and acute
- Discusses the molecular mechanisms and neurobiology of action
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
ISBN-13
978-0-12-821034-5 (9780128210345)
Schweitzer Klassifikation
1. Ketamine, Clio, and the hippocratic triangled fragments of the history of ketamine2. Ketamine's potential mechanism of action for rapid antidepressive effects - a focus on neuroplasticity3. Treatment resistant depression 4. Suicide in psychiatric disorders: rates, risk factors, and therapeutics5. Overview of ketamine for major depression: efficacy and effectiveness6. How to implement a ketamine clinic7. Development of new rapid-action treatments in mood disorders8. Closing remarks
